IOPAMIRON Side Effects

5708589-7 | Brain Scan Abnormal, Clonic Convulsion, Hemianopia, Loss Of Consciousness
on Apr 09, 2008 Female patient from JAPAN , weighting 92.59 lb, was diagnosed with percutaneous coronary intervention, acute myocardial infarction, arteriogram coronary and was treated with Iopamiron (View Usage). Patient experienced the following unwanted or unexpected effects: brain scan abnormal, clonic convulsion, hemianopia, loss of consciousness. Iopamiron dosage: . During the same period patient was treated with OLIVES K (View Olives K Review and Olives K Label ), MYSLEE (View Myslee Review and Myslee Label ), ARTIST (View Artist Review and Artist Label ), PANALDINE (View Panaldine Review and Panaldine Label ), ITOROL (View Itorol Review and Itorol Label ), LIPITOR /01326102/ (View Lipitor /01326102/ Review and Lipitor /01326102/ Label ). Patient was hospitalized.

5680495-6 | Hyperaemia, Hypoxia, Nasal Congestion, Pharyngolaryngeal Discomfort, Rhinorrhoea
Patient was taking Iopamiron (View Usage). Patient had the following side effects: hyperaemia, hypoxia, nasal congestion, pharyngolaryngeal discomfort, rhinorrhoea on Mar 07, 2008 from GERMANY Additional patient health information: Male patient , 49 years of age, was diagnosed with computerised tomogram, adrenal neoplasm and. Iopamiron dosage: . During the same period patient was treated with NEO MINOPHAGEN C (View Neo-minophagen C Review and Neo-minophagen C Label ), SAXIZON (View Saxizon Review and Saxizon Label ), SOLULACT (View Solulact Review and Solulact Label ), POLARAMINE (View Polaramine Review and Polaramine Label ).

5669604-2 | Anaphylactoid Reaction, Blood Pressure Immeasurable, Cardiac Arrest, Cyanosis, Hypoxic Encephalopathy, Loss Of Consciousness, Pyrexia, Respiratory Arrest, Status Asthmaticus
Adverse event was reported on Feb 29, 2008 by a Female patient taking Iopamiron (View Usage) (Dosage: ) was diagnosed with computerised tomogram, breast cancer (What is breast cancer?) and. Location: GERMANY , 46 years of age, After Iopamiron was administered, patient had the following side effects: anaphylactoid reaction, blood pressure immeasurable, cardiac arrest (What is cardiac arrest?), cyanosis, hypoxic encephalopathy, loss of consciousness, pyrexia, respiratory arrest, status asthmaticus. During the same period patient was treated with METILON (View Metilon Review and Metilon Label ), THEOLONG (View Theolong Review and Theolong Label ), TASUOMIN (View Tasuomin Review and Tasuomin Label ), OXYGEN (5 L/min) (View Oxygen Review and Oxygen Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), BOSMIN (View Bosmin Review and Bosmin Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), CATABON (20 Ml/hr) (View Catabon Review and Catabon Label ). Patient was hospitalized and became disabled.

5652452-7 | Blood Pressure Decreased, Burning Sensation, Dyspnoea, Heart Rate Decreased, Loss Of Consciousness, Nausea, Shock, Shunt Occlusion
on Feb 25, 2008 Female patient from JAPAN , 57 years of age, was diagnosed with arteriogram coronary, angina pectoris and was treated with Iopamiron (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, burning sensation, dyspnoea, heart rate decreased, loss of consciousness, nausea (What is nausea?), shock, shunt occlusion. Iopamiron dosage: . During the same period patient was treated with METHYLPREDNISOLONE SODIUM SUCCINATE (View Methylprednisolone Sodium Succinate Review and Methylprednisolone Sodium Succinate Label ), ATROPINE SULFATE (1/2 Ampule) (View Atropine Sulfate Review and Atropine Sulfate Label ), ADRENALIN /00003901/ (1 Ampule) (View Adrenalin /00003901/ Review and Adrenalin /00003901/ Label ), PROTAMINE SULFATE (View Protamine Sulfate Review and Protamine Sulfate Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ). Patient was hospitalized.


5634899-8 | Thrombocytopenia
on Feb 14, 2008 Male patient from GERMANY , 73 years of age, was diagnosed with computerised tomogram, hepatitis c (What is hepatitis c?) and was treated with Iopamiron (View Usage). Patient had the following side effects: thrombocytopenia. Iopamiron dosage: . During the same period patient was treated with PLATELETS (Platelet Transfusion) (View Platelets Review and Platelets Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), ANTITHROMBIN III (View Antithrombin Iii Review and Antithrombin Iii Label ), MYSLEE (View Myslee Review and Myslee Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), MAGMITT (View Magmitt Review and Magmitt Label ).

5621263-0 | Cardio-respiratory Arrest, Dyspnoea, Status Asthmaticus
Patient was taking Iopamiron (View Usage). After Iopamiron was administered, patient had the following side effects: cardio-respiratory arrest, dyspnoea, status asthmaticus on Feb 04, 2008 from GERMANY Additional patient health information: Female patient , 46 years of age, was diagnosed with computerised tomogram and. Iopamiron dosage: . Patient was hospitalized and became disabled.

5618598-4 | Blood Pressure Decreased, Chest Pain, Depressed Level Of Consciousness, Dyspnoea, Pneumonia Aspiration, Shock, Vomiting
Adverse event was reported on Jan 30, 2008 by a Male patient taking Iopamiron (View Usage) (Dosage: ) was diagnosed with computerised tomogram, aortic dissection, hypertension, gastritis and. Location: GERMANY , 51 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, chest pain (What is chest pain?), depressed level of consciousness, dyspnoea, pneumonia aspiration, shock, vomiting. During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), ADALAT (View Adalat Review and Adalat Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ). Patient was hospitalized.

5611813-2 | Platelet Count Decreased
on Jan 28, 2008 Male patient from GERMANY , 73 years of age, was diagnosed with computerised tomogram, hepatitis c (What is hepatitis c?), gastritis, insomnia, constipation (What is constipation?), dermatitis, benign prostatic hyperplasia and was treated with Iopamiron (View Usage). Patient had the following side effects: platelet count decreased. Iopamiron dosage: . During the same period patient was treated with PLATELETS (Platelet Transfusion) (View Platelets Review and Platelets Label ), CORTICOSTEROID NOS (View Corticosteroid Nos Review and Corticosteroid Nos Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), MYSLEE (View Myslee Review and Myslee Label ), MAGMITT (View Magmitt Review and Magmitt Label ), LOCOID (View Locoid Review and Locoid Label ), EVIPROSTAT (View Eviprostat Review and Eviprostat Label ).

5528842-X | Arthralgia, Arthritis Bacterial
on Nov 22, 2007 Female patient from GERMANY , weighting 165.3 lb, was diagnosed with arthralgia and was treated with Iopamiron (View Usage). After Iopamiron was administered, patient had the following side effects: arthralgia, arthritis bacterial. Iopamiron dosage: . During the same period patient was treated with BETADINE /00080001/ (View Betadine /00080001/ Review and Betadine /00080001/ Label ). Patient was hospitalized.

5503944-2 | Aspiration Bronchial, Cardio-respiratory Arrest, Tonic Convulsion
Patient was taking Iopamiron (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration bronchial, cardio-respiratory arrest, tonic convulsion on Oct 30, 2007 from GERMANY Additional patient health information: Male patient , 34 years of age, was diagnosed with spinal myelogram and. Iopamiron dosage: . Patient was hospitalized.

5491771-4 | Blood Pressure Increased, Chest Discomfort, Contrast Media Reaction, Purpura, Renal Impairment
Adverse event was reported on Oct 16, 2007 by a Male patient taking Iopamiron (View Usage) (Dosage: 3 Ml/sec) . Location: GERMANY , 67 years of age, weighting 116.8 lb, Patient had the following side effects: blood pressure increased, chest discomfort, contrast media reaction, purpura, renal impairment. During the same period patient was treated with URSO 250 (View Urso 250 Review and Urso 250 Label ). Patient was hospitalized.

5483973-8 | Cardiac Arrest, Vomiting
on Oct 05, 2007 Male patient from GERMANY , 56 years of age, was diagnosed with aortic dissection and was treated with Iopamiron (View Usage). After Iopamiron was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), vomiting. Iopamiron dosage: .

5483875-7 | Blood Pressure Increased, Chest Discomfort, Purpura, Renal Impairment
on Oct 05, 2007 Male patient from GERMANY , 67 years of age, weighting 116.8 lb, was treated with Iopamiron (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, chest discomfort, purpura, renal impairment. Iopamiron dosage: 3 Ml/sec. During the same period patient was treated with URSO 250 (View Urso 250 Review and Urso 250 Label ).

5481631-7 | Hemiplegia
Patient was taking Iopamiron (View Usage). Patient had the following side effects: hemiplegia on Oct 04, 2007 from GERMANY Additional patient health information: Female patient , 71 years of age, weighting 200.6 lb, was diagnosed with therapeutic embolisation, angiogram cerebral and. Iopamiron dosage: Total Dose. During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ), MELBIN (View Melbin Review and Melbin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

5419717-5 | Hemiplegia
Adverse event was reported on Aug 15, 2007 by a Female patient taking Iopamiron (View Usage) (Dosage: Total Dose) was diagnosed with therapeutic embolisation, angiogram cerebral and. Location: GERMANY , 71 years of age, weighting 200.6 lb, After Iopamiron was administered, patient had the following side effects: hemiplegia. During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ), MELBIN (View Melbin Review and Melbin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

5416955-2 | Hepatitis Fulminant, Renal Failure Acute
on Aug 13, 2007 Male patient from GERMANY , weighting 94.80 lb, was diagnosed with persistent left superior vena cava, coronary artery stenosis, arteriogram coronary and was treated with Iopamiron (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis fulminant, renal failure acute. Iopamiron dosage: . During the same period patient was treated with LIDOCAINE (View Lidocaine Review and Lidocaine Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), KAYTWO (View Kaytwo Review and Kaytwo Label ). Patient was hospitalized.

5407183-5 | Cardiogenic Shock
on Aug 01, 2007 Female patient from GERMANY , 79 years of age, was treated with Iopamiron (View Usage). Patient had the following side effects: cardiogenic shock. Iopamiron dosage: . During the same period patient was treated with GANATON (View Ganaton Review and Ganaton Label ), TAGAMET /00397401/ (View Tagamet /00397401/ Review and Tagamet /00397401/ Label ), CEREKINON (View Cerekinon Review and Cerekinon Label ), MONILAC (View Monilac Review and Monilac Label ). Patient was hospitalized.

5407177-X | Coombs Positive Haemolytic Anaemia, Haemoglobinuria
Patient was taking Iopamiron (View Usage). After Iopamiron was administered, patient had the following side effects: coombs positive haemolytic anaemia, haemoglobinuria on Jul 31, 2007 from GERMANY Additional patient health information: Male patient , child 4 years of age, weighting 38.80 lb, was diagnosed with computerised tomogram and. Iopamiron dosage: 0.4 Ml/sec.

5403750-3 | Blood Pressure Decreased, Electrocardiogram Qrs Complex Prolonged, Electrocardiogram St Segment Elevation, Feeling Abnormal
Adverse event was reported on Jul 20, 2007 by a Female patient taking Iopamiron (View Usage) (Dosage: ) . Location: GERMANY , 79 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, electrocardiogram qrs complex prolonged, electrocardiogram st segment elevation, feeling abnormal.

5390269-1 | Cardiovascular Disorder, Computerised Tomogram Abnormal, Extravasation, Hemiplegia
on Jul 13, 2007 Female patient from GERMANY , 71 years of age, was diagnosed with therapeutic embolisation, angiogram cerebral and was treated with Iopamiron (View Usage). Patient had the following side effects: cardiovascular disorder, computerised tomogram abnormal, extravasation, hemiplegia. Iopamiron dosage: Total Dose. Patient was hospitalized.

5358794-7 | Hepatitis Fulminant, Renal Failure Acute
on Jun 12, 2007 Male patient from GERMANY , 78 years of age, was diagnosed with arteriogram coronary and was treated with Iopamiron (View Usage). After Iopamiron was administered, patient had the following side effects: hepatitis fulminant, renal failure acute. Iopamiron dosage: . During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), KAYTWO (View Kaytwo Review and Kaytwo Label ). Patient was hospitalized.

5355227-1 | Coombs Positive Haemolytic Anaemia, Haemoglobinuria
Patient was taking Iopamiron (View Usage). Patient experienced the following unwanted or unexpected effects: coombs positive haemolytic anaemia, haemoglobinuria on Jun 07, 2007 from GERMANY Additional patient health information: Male patient , child 4 years of age, weighting 38.80 lb, was diagnosed with computerised tomogram and. Iopamiron dosage: 0.4 Ml/sec.

5355136-8 | Hepatitis Fulminant, Renal Failure Acute
Adverse event was reported on Jun 07, 2007 by a Male patient taking Iopamiron (View Usage) (Dosage: ) was diagnosed with arteriogram coronary and. Location: GERMANY , 78 years of age, Patient had the following side effects: hepatitis fulminant, renal failure acute. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), KAYTWO (View Kaytwo Review and Kaytwo Label ). Patient was hospitalized.

5330031-9 | Aortic Aneurysm Rupture, Feeling Abnormal, Injection Site Extravasation, Shock
on May 16, 2007 Male patient from GERMANY , 80 years of age, was diagnosed with computerised tomogram and was treated with Iopamiron (View Usage). After Iopamiron was administered, patient had the following side effects: aortic aneurysm rupture, feeling abnormal, injection site extravasation, shock. Iopamiron dosage: .

5319235-9 | Cataract, Diabetic Retinopathy, Optic Ischaemic Neuropathy, Papilloedema, Vision Blurred, Visual Acuity Reduced
on May 03, 2007 Male patient from GERMANY , 56 years of age, was treated with Iopamiron (View Usage). Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?), diabetic retinopathy, optic ischaemic neuropathy, papilloedema, vision blurred, visual acuity reduced. Iopamiron dosage: .

5309373-9 | Coombs Positive Haemolytic Anaemia, Haematuria
Patient was taking Iopamiron (View Usage). Patient had the following side effects: coombs positive haemolytic anaemia, haematuria on Apr 26, 2007 from GERMANY Additional patient health information: Male patient , child 4 years of age, weighting 38.80 lb, was diagnosed with computerised tomogram and. Iopamiron dosage: 0.4 Ml/sec.

5293270-1 | Chest Discomfort, Flushing, Sneezing, Unevaluable Event, Vomiting
Adverse event was reported on Apr 05, 2007 by a Female patient taking Iopamiron (View Usage) (Dosage: ) was diagnosed with hepatic mass, computerised tomogram and. Location: JAPAN , 68 years of age, After Iopamiron was administered, patient had the following side effects: chest discomfort, flushing, sneezing, unevaluable event, vomiting.

5287967-7 | Cataract, Diabetic Retinopathy, Optic Ischaemic Neuropathy, Papilloedema, Vision Blurred, Visual Acuity Reduced
on Mar 30, 2007 Male patient from GERMANY , 56 years of age, was treated with Iopamiron (View Usage). Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?), diabetic retinopathy, optic ischaemic neuropathy, papilloedema, vision blurred, visual acuity reduced. Iopamiron dosage: .

5287697-1 | Haematuria, Haemolytic Anaemia
on Mar 30, 2007 Male patient from GERMANY , child 4 years of age, weighting 39.68 lb, was diagnosed with computerised tomogram and was treated with Iopamiron (View Usage). Patient had the following side effects: haematuria, haemolytic anaemia. Iopamiron dosage: . Patient was hospitalized.

5287684-3 | Blood Pressure Decreased, Chills, Nausea, Pain, Renal Failure Acute, Rhabdomyolysis, Shock
Patient was taking Iopamiron (View Usage). After Iopamiron was administered, patient had the following side effects: blood pressure decreased, chills, nausea (What is nausea?), pain (What is pain?), renal failure acute, rhabdomyolysis, shock on Mar 29, 2007 from GERMANY Additional patient health information: Female patient , weighting 125.7 lb, . Iopamiron dosage: 20 Ml/min. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), LOCHOL /01224501/ (View Lochol /01224501/ Review and Lochol /01224501/ Label ). Patient was hospitalized.

5278929-4 | Cataract, Diabetic Retinopathy, Optic Ischaemic Neuropathy, Retinal Disorder, Vision Blurred, Visual Acuity Reduced
Adverse event was reported on Mar 23, 2007 by a Male patient taking Iopamiron (View Usage) (Dosage: ) . Location: GERMANY , 56 years of age, Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?), diabetic retinopathy, optic ischaemic neuropathy, retinal disorder (What is retinal disorder?), vision blurred, visual acuity reduced.

5277412-X | Anaphylactic Shock, Aortic Aneurysm Rupture, Feeling Abnormal, Injection Site Extravasation
on Mar 20, 2007 Male patient from GERMANY , 80 years of age, was diagnosed with computerised tomogram and was treated with Iopamiron (View Usage). Patient had the following side effects: anaphylactic shock, aortic aneurysm rupture, feeling abnormal, injection site extravasation. Iopamiron dosage: .

5266897-0 | Blood Pressure Decreased, Cyanosis, Wheezing
on Mar 12, 2007 Male patient from GERMANY , 76 years of age, was diagnosed with computerised tomogram and was treated with Iopamiron (View Usage). After Iopamiron was administered, patient had the following side effects: blood pressure decreased, cyanosis, wheezing. Iopamiron dosage: . Patient was hospitalized.

5262178-X | Erythema Multiforme
Patient was taking Iopamiron (View Usage). Patient experienced the following unwanted or unexpected effects: erythema multiforme on Mar 06, 2007 from GERMANY Additional patient health information: Female patient , 74 years of age, was diagnosed with arteriogram coronary and. Iopamiron dosage: . During the same period patient was treated with TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ).

5255974-6 | Blood Pressure Decreased, Chills, Nausea, Pain, Renal Failure Acute, Rhabdomyolysis, Shock
Adverse event was reported on Mar 01, 2007 by a Female patient taking Iopamiron (View Usage) (Dosage: 20 Ml/min) . Location: GERMANY , weighting 125.7 lb, Patient had the following side effects: blood pressure decreased, chills, nausea (What is nausea?), pain (What is pain?), renal failure acute, rhabdomyolysis, shock. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), LOCHOL /01224501/ (View Lochol /01224501/ Review and Lochol /01224501/ Label ). Patient was hospitalized.

5247369-6 | Blood Pressure Decreased, Pain, Pyrexia, Renal Failure Acute, Shock
on Feb 21, 2007 Female patient from GERMANY , 60 years of age, weighting 125.7 lb, was diagnosed with calculus urinary and was treated with Iopamiron (View Usage). After Iopamiron was administered, patient had the following side effects: blood pressure decreased, pain (What is pain?), pyrexia, renal failure acute, shock. Iopamiron dosage: . Patient was hospitalized.

5231379-9 | Arteriospasm Coronary, Blood Pressure Decreased, Chest Pain, Depressed Level Of Consciousness, Dyspnoea, Electrocardiogram St Segment Elevation, Feeling Abnormal, Oxygen Saturation Decreased, Shock
on Jan 30, 2007 Male patient from GERMANY , 65 years of age, weighting 123.5 lb, was diagnosed with computerised tomogram and was treated with Iopamiron (View Usage). Patient experienced the following unwanted or unexpected effects: arteriospasm coronary, blood pressure decreased, chest pain (What is chest pain?), depressed level of consciousness, dyspnoea, electrocardiogram st segment elevation, feeling abnormal, oxygen saturation decreased, shock. Iopamiron dosage: 2 Ml. During the same period patient was treated with TANATRIL (View Tanatril Review and Tanatril Label ), PARIET (View Pariet Review and Pariet Label ), URSO (View Urso Review and Urso Label ), LIVACT (Granules) (View Livact Review and Livact Label ), BERIZYM (Granules) (View Berizym Review and Berizym Label ), CAMOSTAT MESILATE (View Camostat Mesilate Review and Camostat Mesilate Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5191916-X | Anaphylactic Shock, Blood Pressure Decreased, Depressed Level Of Consciousness, Gastrointestinal Haemorrhage, Herpes Zoster, Pancreatitis Acute, Pneumonia, Respiratory Failure
Patient was taking Iopamiron (View Usage). Patient had the following side effects: anaphylactic shock, blood pressure decreased, depressed level of consciousness, gastrointestinal haemorrhage, herpes zoster, pancreatitis acute, pneumonia (What is pneumonia?), respiratory failure on Nov 17, 2006 from GERMANY Additional patient health information: Female patient , weighting 123.5 lb, was diagnosed with computerised tomogram coronary artery and. Iopamiron dosage: 4 Ml/sec. During the same period patient was treated with SELOKEN /00376902/ (View Seloken /00376902/ Review and Seloken /00376902/ Label ), NITROPEN (View Nitropen Review and Nitropen Label ), ZANTAC (View Zantac Review and Zantac Label ), SLOW K (View Slow-k Review and Slow-k Label ), CALSLOT (View Calslot Review and Calslot Label ), BUFFERIN /00009201/ (View Bufferin /00009201/ Review and Bufferin /00009201/ Label ), APLACE (View Aplace Review and Aplace Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ).

5181051-9 | Atelectasis, Gastric Ulcer, Haemangioma Of Liver, Malaise, Platelet Count Decreased, Pneumonia, White Blood Cell Count Decreased
Adverse event was reported on Oct 27, 2006 by a Male patient taking Iopamiron (View Usage) (Dosage: 4.3 Ml/sec) was diagnosed with vertebrobasilar insufficiency and. Location: GERMANY , weighting 132.3 lb, After Iopamiron was administered, patient had the following side effects: atelectasis, gastric ulcer, haemangioma of liver, malaise, platelet count decreased, pneumonia (What is pneumonia?), white blood cell count decreased. During the same period patient was treated with KETAS (View Ketas Review and Ketas Label ). Patient was hospitalized.

5167000-8 | Haemodialysis, Mucosal Ulceration, Stevens-johnson Syndrome
on Nov 24, 2006 Female patient from GERMANY , 58 years of age, was treated with Iopamiron (View Usage). Patient experienced the following unwanted or unexpected effects: haemodialysis, mucosal ulceration, stevens-johnson syndrome. Iopamiron dosage: . During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ).

5151537-1 | Dermatitis Exfoliative, Malaise, Nausea, Oral Intake Reduced, Pyrexia
on Sep 14, 2006 Female patient from GERMANY , 63 years of age, was diagnosed with angina pectoris, computerised tomogram and was treated with Iopamiron (View Usage). Patient had the following side effects: dermatitis exfoliative, malaise, nausea (What is nausea?), oral intake reduced, pyrexia. Iopamiron dosage: . During the same period patient was treated with PANALDINE (View Panaldine Review and Panaldine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CYTOTEC (View Cytotec Review and Cytotec Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ANPLAG (View Anplag Review and Anplag Label ), MAALOX FAST BLOCKER (View Maalox Fast Blocker Review and Maalox Fast Blocker Label ), MUCOSTA (View Mucosta Review and Mucosta Label ).

5151380-3 | Gastric Ulcer, Haemangioma Of Liver, Malaise, Platelet Count Decreased, Pneumonia, White Blood Cell Count Decreased
Patient was taking Iopamiron (View Usage). After Iopamiron was administered, patient had the following side effects: gastric ulcer, haemangioma of liver, malaise, platelet count decreased, pneumonia (What is pneumonia?), white blood cell count decreased on Oct 27, 2006 from GERMANY Additional patient health information: Male patient , 78 years of age, weighting 132.3 lb, was diagnosed with vertebrobasilar insufficiency and. Iopamiron dosage: 4.3 Ml/sec. During the same period patient was treated with KETAS (View Ketas Review and Ketas Label ). Patient was hospitalized.

5148925-6 | Glaucoma
Adverse event was reported on Nov 07, 2006 by a Female patient taking Iopamiron (View Usage) (Dosage: ) . Location: GERMANY , 68 years of age, Patient experienced the following unwanted or unexpected effects: glaucoma (What is glaucoma?). Patient was hospitalized.

5148820-2 | Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Transaminases Increased
on Oct 19, 2006 Male patient from GERMANY , 59 years of age, weighting 110.2 lb, was diagnosed with computerised tomogram and was treated with Iopamiron (View Usage). Patient had the following side effects: blood alkaline phosphatase increased, gamma-glutamyltransferase increased, transaminases increased. Iopamiron dosage: . During the same period patient was treated with TS 1 (View Ts 1 Review and Ts 1 Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PARIET (View Pariet Review and Pariet Label ), RINDERON /00008501/ (View Rinderon /00008501/ Review and Rinderon /00008501/ Label ). Patient was hospitalized.

5148819-6 | Agitation, Cyanosis, Hyperthermia, Tremor
on Sep 22, 2006 Female patient from GERMANY , 67 years of age, was diagnosed with angiogram cerebral and was treated with Iopamiron (View Usage). After Iopamiron was administered, patient had the following side effects: agitation, cyanosis, hyperthermia, tremor. Iopamiron dosage: . During the same period patient was treated with CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ).

5147915-7 | Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Transaminases Increased
Patient was taking Iopamiron (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, gamma-glutamyltransferase increased, transaminases increased on Oct 19, 2006 from GERMANY Additional patient health information: Male patient , 59 years of age, weighting 110.2 lb, was diagnosed with computerised tomogram and. Iopamiron dosage: . During the same period patient was treated with TS 1 (View Ts 1 Review and Ts 1 Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PARIET (View Pariet Review and Pariet Label ), RINDERON /00008501/ (View Rinderon /00008501/ Review and Rinderon /00008501/ Label ). Patient was hospitalized.

5147914-5 | Agitation, Cyanosis, Hyperthermia, Tremor
Adverse event was reported on Sep 22, 2006 by a Female patient taking Iopamiron (View Usage) (Dosage: ) was diagnosed with angiogram cerebral and. Location: GERMANY , 67 years of age, Patient had the following side effects: agitation, cyanosis, hyperthermia, tremor. During the same period patient was treated with CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ).

5144034-0 | Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Transaminases Increased
on Oct 19, 2006 Male patient from GERMANY , 59 years of age, weighting 110.2 lb, was diagnosed with computerised tomogram and was treated with Iopamiron (View Usage). After Iopamiron was administered, patient had the following side effects: blood alkaline phosphatase increased, gamma-glutamyltransferase increased, transaminases increased. Iopamiron dosage: . During the same period patient was treated with TS 1 (View Ts 1 Review and Ts 1 Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PARIET (View Pariet Review and Pariet Label ), RINDERON /00008501/ (View Rinderon /00008501/ Review and Rinderon /00008501/ Label ). Patient was hospitalized.

5142178-0 | Cyanosis, Dysphonia, Dyspnoea, Erythema, Loss Of Consciousness, Malaise
on Jun 02, 2006 Male patient from GERMANY , 70 years of age, was treated with Iopamiron (View Usage). Patient experienced the following unwanted or unexpected effects: cyanosis, dysphonia, dyspnoea, erythema, loss of consciousness, malaise. Iopamiron dosage: .

5140252-6 | Malaise, Platelet Count Decreased, White Blood Cell Count Decreased
Patient was taking Iopamiron (View Usage). Patient had the following side effects: malaise, platelet count decreased, white blood cell count decreased on Oct 27, 2006 from GERMANY Additional patient health information: Male patient , 78 years of age, weighting 132.3 lb, was diagnosed with computerised tomogram and. Iopamiron dosage: . Patient was hospitalized.